Targeting the PI3K pathway in Breast Cancer by Jose Baselga, MD, PhD

Targeting the Breast Cancer Genome and the Shaping of Precision Medicine - Jose Baselga, M.D., Ph.D.Подробнее

Dr. Baselga Discusses the BOLERO Breast Cancer TrialsПодробнее

Dr. Baselga Discusses Targeting PI3K in Breast CancerПодробнее

Targeting the Phosphoinositide-3 Kinase (PI3K) Pathway in Breast Cancer - José Baselga, MDПодробнее

Targeting the PI3k pathway in breast cancer (José Baselga, USA)Подробнее

Dr. Baselga Discusses PIK3CA Inhibitors in Breast CancerПодробнее

Dr. Chandarlapaty on Role of the PI3K Pathway in Breast CancerПодробнее

Targeting the PI3K pathway in Breast CancerПодробнее

Dr. Jose Baselga Describes the Investigation of pan-PI3 Kinase Inhibitors in Breast CancerПодробнее

Targeting the PI3K Pathway in the Therapy of Breast CancerПодробнее

Keynote - Novel Therapeutics in Cancer (Jose Baselga)Подробнее

Targeting the Phosphoinositide-3 Kinase (PI3K) Pathway in Breast CancerПодробнее

The PI3K pathway - Lewis Cantley, PhDПодробнее

Explanations of targeted therapies and their impact on breast cancer treatmentПодробнее

PI3K Inhibitors for HR+ Metastatic Breast CancerПодробнее

Targeting the PI3K-Akt-mTOR PathwayПодробнее

Dr. Baselga on Biomarker Research for Breast CancerПодробнее

Dr. Baselga Describes the Advantages of Dual BlockadeПодробнее

The PI3K PathwayПодробнее